Among the technologies represented by the group are medtech sensors tracking blood pressure, ostomy patient complications, tremor progression in Parkinson's disease patients, balance, cerebrospinal fluid levels, and more.
Check out news from Vivalink, HealthMine, Vitable Health and more.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
Vivalink CEO Jiang Li said the platform consists of wearable sensors to capture human vitals and biometrics, edge-to-cloud IoT network, data management, and algorithms.